Texas 2011 - 82nd Regular

Texas House Bill HB1644

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to health benefit plan coverage for certain tests for the early detection of cardiovascular disease in certain children.

Impact

If enacted, HB 1644 would lead to significant changes in state healthcare policies regarding children's health. The law would ensure that health plans in Texas are required to cover specific cardiovascular screenings, thereby reducing financial barriers for families. This move is expected to improve early detection rates of potentially life-threatening heart conditions among children, contributing to better health outcomes and possibly preventing tragic events related to undetected heart issues.

Summary

House Bill 1644 aims to enhance healthcare coverage for early detection of cardiovascular diseases in children. Specifically, the bill mandates that health benefit plans provide minimum coverage for screening procedures for individuals aged 11 to 17 who are students at middle schools in Texas or those who have not undergone heart-related tests within the last two years. The bill stipulates that insurers must cover tests including thorough medical histories, focused physical examinations, electrocardiograms, and limited echocardiograms, all aimed at identifying asymptomatic conditions that could lead to sudden cardiac arrest in children.

Sentiment

The general sentiment surrounding HB 1644 seems to be supportive, especially among health advocates and organizations focused on children's welfare. Proponents argue that the bill addresses a critical need for proactive health screenings in the youth population, which can save lives by facilitating early intervention. However, there may be concerns about the financial implications for health insurers and questions about the sufficiency of the coverage mandated by the bill.

Contention

One notable point of contention could arise regarding the implementation of the bill, particularly around its cost and the impact on health insurance premiums. Some critics may argue that mandating coverage for additional screenings could lead to higher costs for insurers, which in turn could be passed on to consumers. Additionally, questions may surface about the adequacy of the training and resources available to healthcare providers tasked with conducting these screening procedures, especially in less accessible regions of the state.

Companion Bills

No companion bills found.

Previously Filed As

TX SB989

Relating to health benefit plan coverage for certain biomarker testing.

TX HB3188

Relating to health benefit plan coverage for certain biomarker testing.

TX HB118

Relating to health benefit plan coverage for certain tests to detect prostate cancer.

TX HB826

Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.

TX SB1221

Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.

TX HB389

Relating to health benefit coverage for certain fertility preservation services under certain health benefit plans.

TX SB447

Relating to health benefit coverage for certain fertility preservation services under certain health benefit plans.

TX SB1277

Relating to health benefit coverage for certain fertility preservation services under certain health benefit plans.

TX HB526

Relating to HIV and AIDS tests and to health benefit plan coverage of HIV and AIDS tests.

TX HB1128

Relating to availability of and benefits provided under health benefit plan coverage.

Similar Bills

No similar bills found.